Flamel Technologies (FLML) Misses Q1 EPS by 10c
Get Alerts FLML Hot Sheet
Join SI Premium – FREE
Flamel Technologies (NASDAQ: FLML) reported Q1 EPS of $0.04, $0.10 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $36.2 million versus the consensus estimate of $34 million.
The Company is maintaining its full year 2016 revenue guidance of $110 - $130 million and expects the recently acquired FSC products, AcipHex Sprinkle", Karbinal" ER, Cefaclor for Oral Suspension and Flexichamber", to contribute revenues in the range of $10 - $15 million. As a result of the multiple clinical trials expected to run throughout 2016, the Company expects research & development expenses to be in the range of $35 - $50 million, up from $25.6 million in 2015.
For earnings history and earnings-related data on Flamel Technologies (FLML) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- VIST Financial Corp. (VIST) Misses Q1 EPS by 19c
- Celestica (CLS) Tops Q1 EPS by 14c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!